Evidence map›Paper›PMID 41082656›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease.

Xurde M Caravia, Brian Hayashi, Hui Li, Peiheng Gan, Damir Alzhanov, Wei Tan, Kenian Chen, John R McAnally, Lin Xu, Ning Liu and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. CRISPR-mediated targeting of theMolecular therapy. Advances · 2026
    Article
  6. HomozygousFrontiers in cardiovascular medicine · 2026
    Article
  7. Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xurde M CaraviaDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Brian HayashiDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0009-0005-4004-5451
Hui LiDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-4114-8349
Peiheng GanDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Damir AlzhanovDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Wei TanDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Kenian ChenQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390.
John R McAnallyDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Lin XuQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Ning LiuDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Eric N OlsonDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0003-1151-8262

Funding

Training CoreP50HD087351 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI BASSEL-DUBY, RHONDA, IANNACCONE, SUSAN T · 2020 to 2024
$8.0M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI JAY D. HORTON · 2022 to 2026
$7.4M
Deciphering the role of a novel micropeptide in cardiac function and dysfunctionR01HL130253 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI BASSEL-DUBY, RHONDA, OLSON, ERIC N · 2016 to 2023
$4.4M
Transcriptional Control of Neonatal Heart RegenerationR01HL157281 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI BASSEL-DUBY, RHONDA, OLSON, ERIC N · 2022 to 2025
$2.2M
RBPMS, a novel RNA splicing regulator of cardiac function and diseaseR00HL171888 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI Peiheng Gan · 2025 to 2026
$498k
HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL130253HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL157281HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1K99HL171887-01A1HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50HD087351NHLBI NIH HHS R00 HL171888NICHD NIH HHS P50 HD087351NIDDK NIH HHS P30 DK127984the British Heart Foundation BBC/F/21/220106The Leducq Foundation Transatlantic Networks of Excellence LeducqThe Robert A. Welch Foundation 1-0025
6 · The paper itself

Abstract

Mutations in the Lamin A (

Indexed as

Cardiomyopathy, DilatedGene EditingLamin Type AMutationAnimalsDisease Models, AnimalHumansInduced Pluripotent Stem CellsMiceMuscular DystrophiesMyocytes, CardiacLamin Type ALMNA protein, humancardiomyopathygene editingLMNA

Identifiers

PMID41082656
PMCPMC12582316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.